With growth moderation expected in FY20E, we expect revenue, EBITDA and PAT to grow at 9.8%, 8.1% and 4.3% CAGR, respectively, in FY19-21E. NRB has executed a capex of ~Rs 50 crore in FY19. The company currently operates at utilisation levels of ~80%. For FY20-21E, NRB has planned a capex ~| 100-150 crore. Debt levels have gone up from ~Rs 173 crore in FY18 to ~Rs 260 crore in FY19. Going ahead, debt levels’ working capital management will be the key monitorable. We value NRB at ~15x FY21E earnings to arrive at a target price of Rs 185 per share. We have a HOLD recommendation on the stock.